Results from the children's study will be presented June 10th in San Diego

On Saturday, June 10, Erik Ising, PhD student at the Department of Clinical Sciences Malmö - Pediatric Endocrinology will presents his findings from a study using VibroSense instruments for detection of early signs of neuropathy in childhood and adolescents type 1 diabetes.

The results are presented at a poster session included in the category "Complications-Neuropathy" at the American Diabetes Association's 77th Scientific Sessions in San Diego, California, June 9-13.

Toni Speidel, CEO VibroSense Dynamics AB,
Tel: +46 40 650 14 12
E-mail: info@vibrosense.com
www.vibrosense.com

VibroSense Dynamics AB (public) develops and markets efficient systems for early detection and diagnosis of peripheral sensory neuropathy, i.e. disease of large nerve fibres and nerve trunks in the legs and arms. The Company, founded in 2005, has been listed on AktieTorget since May 2015.